Nutrition Intervention for Women With Polycystic Ovary Syndrome
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: FertilOMed Diet, MedDiet.
- Who it may be relevant to
- Registry conditions: PCOS- Polycystic Ovary Syndrome, Nutrition Intervention, Nutrition Assessment. Basic parameters: 20 years — 45 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Nutrition Intervention in PCOS: Clinical, Biochemical, and Symptomatic Effects of Different Dietary Models
Overview
The goal of this clinical trial is to evaluate whether different dietary models can improve clinical, metabolic, hormonal, anthropometric, and quality-of-life parameters in women with polycystic ovary syndrome (PCOS). The main questions it aims to answer are: * Do the Mediterranean Diet and the FertilOMed Diet (Fertility-Optimized Mediterranean Diet) lead to significant improvements in these parameters compared to the control group? * Does the FertilOMed Diet lead to greater improvements compared to the standard Mediterranean Diet? Study Description: This randomized controlled intervention study will be conducted between November 2025 and March 2026 at the Samsun Training and Research Hospital, Department of Obstetrics and Gynecology, Women's Health Outpatient Clinics. Necessary institutional permissions have been obtained for conducting the study at these sites. Participants: Women diagnosed with PCOS who meet the inclusion criteria and volunteer to participate will be included in the study. Interventions: Participants will be randomly assigned to one of the following groups: * Mediterranean Diet group * FertilOMed Diet group (Fertility-Optimized Mediterranean Diet) * Control group (standard dietary recommendations) Researchers will compare these groups to determine whether the dietary interventions improve clinical, biochemical, and symptomatic outcomes in women with PCOS.
Detailed description
This study will include volunteer female individuals who have applied to the Gynecology and Obstetrics outpatient clinic of the Gynecology and Obstetrics Department of Samsun Training and Research Hospital, diagnosed with PCOS by a physician, and selected according to inclusion and exclusion criteria. Women who meet the criteria will be informed about the study's objectives and methodology, and those who agree to participate will be asked to sign a consent form. Individuals will be assigned to control and intervention groups, matched by age and BMI. Care will be taken to ensure that the groups are matched by age and body mass index (BMI). At the beginning of the study, a questionnaire containing sociodemographic information, general health information, dietary habits, physical activity status, sleep habits, morningness-eveningness scale, PCOS-50 Quality of Life scale, Beck depression scale, SF-36 scale, and food consumption record will be administered to the individuals via face-to-face interviews by the researcher. Initial anthropometric measurements of the female volunteers will be taken by the researcher using appropriate techniques. Additionally, biochemical findings will be obtained from hospital records at the beginning and end of the study. Volunteers, matched by age and BMI, were included in the control and intervention groups and will be followed for 12 weeks. Individuals in the control group will receive only medical treatment throughout the study period. They will be free to make food choices without energy restrictions (ad libitum). No dietary intervention will be implemented. Individuals in the intervention groups will receive ad libitum nutrition education and brochures about the diet's content, in addition to their medical treatment. Individuals in both intervention groups will not be restricted in their daily dietary energy intake.
During the 12-week follow-up period, individuals will be closely monitored through mobile applications and routine follow-up visits.
Interventions
- Other FertilOMed Diet
FertilOMed Diet (Experimental): Participants will follow the FertilOMed Diet, which is based on the standard Mediterranean Diet guidelines, with required consumption of specific foods and adherence to recommended food group portions. Dietary adherence will be monitored through food diaries and follow-up consultations. - Other MedDiet
Mediterranean Diet (Active Comparator): Participants will follow a standard Mediterranean Diet for the duration of the study. Dietary adherence will be monitored through food diaries and follow-up consultations.
Primary outcome measures
- Changes in Hormonal Profile [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Changes in Metabolic Profile [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Changes in Oxidative Stress [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
Secondary outcome measures (12)
- Changes in Body Mass Index (BMI) [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Waist Circumference [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Hip Circumference [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Waist-to-Hip Ratio [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Neck Circumference [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Body Fat Percentage [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Lean Mass [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Muscle Mass [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Total Body Water [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Depression Symptoms (Beck Depression Inventory) [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in PCOS-Specific Quality of Life (PCOSQ-50) [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
- Change in Health-Related Quality of Life (SF-36) [Time frame: Participants follow the dietrary intervention and are assessed at baseline and at the end of the 12-week intervention.]
Eligibility criteria
Inclusion criteria
- Being diagnosed with PCOS according to the Rotterdam Criteria, between the ages of 20 and 45,
- Having a Body Mass Index (BMI) of 18.50-35.00 kg/m2,
- Not having used antibiotics and/or probiotics in the last month,
- Signing a voluntary consent form.
Exclusion criteria
- Being younger than 20 years old or older than 45 years old with PCOS diagnosis,
- Having a BMI of ≤18.50 kg/m2 and ≥35.00 kg/m2,
- Being pregnant or breastfeeding,
- Using alcohol,
- Having used antibiotics and/or probiotics in the last month,
- Having had bariatric surgery,
- Having type 1 diabetes, type 2 diabetes, Cushing's syndrome, hypothyroidism, androgen tumors, active cancer, or a gastrointestinal system or malabsorption disease,
- Having used hormonal contraceptives or insulin sensitivity-enhancing medications within 3 months before the study start,
- Having used antioxidant supplements such as vitamin C within 1 month before the study start,
- Having a Mediterranean Diet Adherence Score (MEDAS) of ≥10,
- Those who did not give their consent after reading the informed consent form.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Non-randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Ondokuz Mayıs University Kurupelit Campus — Samsun
Identifiers
NCT: NCT07298603 · B.30.2ODM.0.20.08/569